Renata Limited

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Renata Limited
Limited Company
Traded asDSERENATA
IndustryPharmaceutical
Founded1993; 26 years ago (1993)
Headquarters,
Bangladesh
Area served
South Asia, South East Asia, Africa, Europe and Latin America
Key people
Syed S Kaiser Kabir (CEO)
ProductsRanitidine,Maxpro,Rolac,Normens and more
Number of employees
3485
Websiterenata-ltd.com

Renata Limited (formerly Pfizer Laboratories (Bangladesh) Limited), also known as Renata, is one of the top ten (in terms of revenue)[1] pharmaceutical manufacturers in Bangladesh. Renata is engaged in the manufacture and marketing of human pharmaceutical and animal health products.[2] The company also manufactures animal therapeutics and nutrition products. Renata currently employs about 2300 people in its head office in Mirpur, Dhaka and its two production facilities in Mirpur, Dhaka and Rajendrapur, Dhaka.[3]


There are three subsidiaries of Renata Limited. These are Renata Agro Industries Limited, Purnava Limited, and Renata Oncology Limited[4]

Renata Limited have successfully synthesized the active pharmaceutical ingredients, Sorafenib, which is used to treat various cancers.[5]

Financial data[edit]

Renata is a publicly traded company on the Dhaka Stock Exchange (ticker: RENATA).[6]

Production facilities[edit]

Recently, Renata Limited has received the UK MHRA approval for its Potent Product Facility.[7] This facility currently manufactures hormone, steroid and cytotoxic drugs,[8] and is exporting prednisolone to the UK.[9]

The company also operates four other manufacturing units – the original Pfizer facility for general products, a UNICEF-approved SFF (Sachet Filling Facility).[10]

Partnerships[edit]

Recently, GAIN (The Global Alliance for Improved Nutrition) provided US$2.9 million to Renata Limited and BRAC, one of the biggest NGOs in the developing world, to build and operate an innovative business model to produce and deliver multi-nutrient powders to vulnerable infants in Bangladesh.[11]


References[edit]

  1. ^ Haroon, Jasim Uddin (15 February 2010). "Square tops list of 10, Incepta second". The Financial Express. Dhaka. Archived from the original on 1 October 2011.
  2. ^ http://www.datamonitor.com/store/Product/renata_limited?productid=91312953-CEAB-43EF-8BD0-5A907E2C3ACF
  3. ^ https://www.google.com/finance?q=DSE:RENATA
  4. ^ https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=280556736
  5. ^ http://www.pharmajogot.com/renata-synthesized-sorafenib-api-first/
  6. ^ "Renata Ltd (RENATA:Dhaka)". Bloomberg Businessweek. Archived from the original on 5 October 2012.
  7. ^ Chowdhury, Raihan M. (10 November 2007). "Pharmaceutical sector development necessitates vertical integration". The Financial Express. Dhaka.
  8. ^ http://nation.ittefaq.com/issues/2008/11/14/all0712.htm
  9. ^ Khan, Jasim Uddin (4 June 2008). "Renata set to export medicine to Europe". The Daily Star.
  10. ^ http://www.gainhealth.org/about-gain/participants#R
  11. ^ http://www.gainhealth.org/press-releases/AR08-09

External links[edit]